These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1905420)

  • 1. Clinical, serological, and immunogenetic studies of systemic sclerosis.
    Maddison PJ
    Rev Rhum Mal Osteoartic; 1991 May; 58(5):369-70. PubMed ID: 1905420
    [No Abstract]   [Full Text] [Related]  

  • 2. The pleomorphism of systemic sclerosis: are we ready for 'personalized medicine' in scleroderma?
    Steen VD
    Expert Rev Clin Immunol; 2011 Jul; 7(4):403-5. PubMed ID: 21790281
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoantibodies and clinical subsets: relevance to scleroderma.
    Maddison PJ
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):684-6. PubMed ID: 11020957
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic association studies in systemic sclerosis: more evidence of a complex disease.
    Fonseca C; Denton CP
    J Rheumatol; 2007 May; 34(5):903-5. PubMed ID: 17477471
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolated pulmonary hypertension in the grandchild of a kindred with scleroderma (systemic sclerosis): "neonatal scleroderma"?
    Morse JH; Barst RJ; Whitman HH; Fotino M; Jacobs JC
    J Rheumatol; 1989 Dec; 16(12):1536-41. PubMed ID: 2625683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of interferon-gamma containing gel for local treatment of skin ulcers in autoimmune vasculitides and skin changes in progressive systemic sclerosis.
    Arnaudova P; Rashkov R; Tsanev R
    J Rheumatol; 1993 Aug; 20(8):1445-6. PubMed ID: 8230042
    [No Abstract]   [Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic antibodies in patients with systemic sclerosis.
    Manolova I; Dancheva M
    J Rheumatol; 2003 Sep; 30(9):2078-9; author reply 2079-80. PubMed ID: 12966621
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to NOR 90/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response.
    Dagher JH; Scheer U; Voit R; Grummt I; Lonzetti L; Raymond Y; Senécal JL
    J Rheumatol; 2002 Jul; 29(7):1543-7. PubMed ID: 12136917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of anti-Scl-70 antibody and its clinical significance in progressive systemic sclerosis.
    Jiang M; Song QF; Wang SZ; Yuan X; Zhang NZ
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(4):247-9. PubMed ID: 3124097
    [No Abstract]   [Full Text] [Related]  

  • 12. [Classification of progressive systemic scleroderma].
    Holzmann H; Sollberg S; Altmeyer P
    Hautarzt; 1987 May; 38(5):253-7. PubMed ID: 3497136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory profile of systemic sclerosis in northern India.
    Kumar A; Malaviya AN; Tiwari SC; Singh RR; Kumar A; Pande JN
    J Assoc Physicians India; 1990 Oct; 38(10):765-8. PubMed ID: 2084078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [REST and CREST syndromes: etiopathogenetic, clinical and therapeutic aspects of partial forms of progressive systemic sclerosis].
    Paggi A; Leri O; Gallo L; Moroni M; Coppotelli L; Uccelli A
    Clin Ter; 1984 Feb; 108(4):327-34. PubMed ID: 6232070
    [No Abstract]   [Full Text] [Related]  

  • 15. Criteria for the classification of early systemic sclerosis.
    LeRoy EC; Medsger TA
    J Rheumatol; 2001 Jul; 28(7):1573-6. PubMed ID: 11469464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to systemic sclerosis from clinical aspect to genetic factor analyses.
    Granel B; Bernard F; Chevillard C
    Eur J Intern Med; 2009 May; 20(3):242-52. PubMed ID: 19393491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized scleroderma and systemic sclerosis: is there a connection?
    Gupta RA; Fiorentino D
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progressive systemic sclerosis. A diagnostic problem].
    Posada de la Paz M; Martínez L de Letona J; Masa Vázquez C; Ruiz Galiana J; Pérez Alvarez R; Díez García F; Pérez Maestu R
    Rev Clin Esp; 1983 Sep; 170(6):237-41. PubMed ID: 6361922
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic significance of scleroderma and myositis-associated autoantibodies].
    Genth E; Mierau R
    Z Rheumatol; 1995; 54(1):39-49. PubMed ID: 7725809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on the article "Hypocomplementemia in systemic sclerosis" by Cuomo G. et al.
    Hudson M; Steele R; Lu Y
    Reumatismo; 2009; 61(2):156-8; author reply 158. PubMed ID: 19633804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.